Supreme Court Report

Supreme Court of the United States · Official docket →

Margaret Temponeras v. United States

Paid petition · United States Court of Appeals for the Sixth Circuit, No. 20-3192 · judgment October 16, 2020


Certiorari denied · April 19, 2021
Pre-decision estimate: 3% cert probability

Before the decision, well below the 4.1% base rate, with no standout signals pointing toward a grant.

Question presented

The Controlled Substances Act, 21 U.S.C. § 841, and its corresponding regulation at 21 C.F.R. § 1306.04 are hopelessly vague laws that criminalize perfectly reasonable behavior by medical doctors. The federal circuits have wild, differing interpretations of how to apply these vague laws and a circuit split is painfully obvious here. Unlike a standard medical practice, prescribing pain medication is an integral part of a pain management practice making the term “legitimate medical purpose” inherently vague. Prosecutors have arbitrarily applied these laws to secure criminal convictions even though doctors were prescribing lawful medications pursuant to the standards set forth by medical boards and pharmaceutical companies. This Court’s intervention is desperately needed here. The question presented is: 1. Whether 21 U.S.C. § 841 and 21 C.F.R. § 1306.04 are unconstitutionally vague whereas the term “legitimate medical purpose” does not provide fair notice of a standard upon which pain management medical practices can be held criminally liable.

Counsel of record

For petitioner
Alexandra Crisanthi Siskopoulos
Siskopoulos Law Firm, LLP

For respondent
Brian H. Fletcher
Acting Solicitor General

Case

Conference history
Distributed for 1 conference

Proceedings

  1. Apr 19 2021
    Petition DENIED.
  2. Mar 24 2021
    DISTRIBUTED for Conference of 4/16/2021.
  3. Mar 19 2021
    Waiver of right of respondent United States of America to respond filed.
  4. Mar 12 2021
    Petition for a writ of certiorari filed. (Response due April 16, 2021)